A novel power prior approach for borrowing historical control data in clinical trials
Statistical Methods in Medical Research · 2023-03 · 32 (3) · 493-508
DOI: 10.1177/09622802221146309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Methods in Medical Research, online erschienen am 04.01.2023. Verfasst von Yaru Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Late Development Statistics, Biostatistics and Research Decision Sciences, 2793Merck & Co., Inc., North Wales, PA, USA. Hauptthemen laut MEDLINE: Models, Statistical, Research Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
There has been an increased interest in borrowing information from historical control data to improve the statistical power for hypothesis testing, therefore reducing the required sample sizes in clinical trials. To account for the heterogeneity between the historical and current trials, power priors are often considered to discount the information borrowed from the historical data. However, it can be challenging to choose a fixed power prior parameter in the application. The modified power prior approach, which defines a random power parameter with initial prior to control the amount of historical information borrowed, may not directly account for heterogeneity between the trials. In this paper, we propose a novel approach to pick a power prior based on some direct measures of distributional differences between historical control data and current control data under normal assumptions. Simulations are conducted to investigate the performance of the proposed approach compared with current approaches (e.g. commensurate prior, meta-analytic-predictive, and modified power prior). The results show that the proposed power prior improves the study power while controlling the type I error within a tolerable limit when the distribution of the historical control data is similar to that of the current control data. The method is developed for both superiority and non-inferiority trials and is illustrated with an example from vaccine clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Late Development Statistics, Biostatistics and Research Decision Sciences, 2793Merck & Co., Inc., North Wales, PA, USA.
- Vaccine Clinical Research & Development, 2253Pfizer, Inc., Collegeville, PA, USA.
ORCID-Profile: Yaru Shi
Zitieren
APA
Shi, Y., Li, W., & Liu, G. F. (2023). A novel power prior approach for borrowing historical control data in clinical trials. Statistical Methods in Medical Research, 32(3), 493-508. https://doi.org/10.1177/09622802221146309
Vancouver
Shi Y, Li W, Liu GF. A novel power prior approach for borrowing historical control data in clinical trials. Statistical Methods in Medical Research. 2023;32(3):493-508. doi:10.1177/09622802221146309
BibTeX
@article{Shi2023,
author = {Shi, Yaru and Li, Wen and Liu, Guanghan Frank},
title = {A novel power prior approach for borrowing historical control data in clinical trials},
journal = {Statistical Methods in Medical Research},
year = {2023},
volume = {32},
number = {3},
pages = {493--508},
doi = {10.1177/09622802221146309}
}
EUVIMED